The atypical cannabinoid O-1602 shows antitumorigenic effects in colon cancer cells and reduces tumor growth in a colitis-associated colon cancer model

Por Kargl, Julia, Haybäck, Johannes, Stančić, Angela A, Marsche, Gunther, Heinemann, Ákos, Schicho, Rudolf
Publicado em 2012

O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms

Por Kargl, Julia, Haybaeck, Johannes, Stanc̆ić, Angela, Andersen, Liisa, Marsche, Gunther, Heinemann, Akos, Schicho, Rudolf
Publicado em 2012

The GPR55 antagonist CID16020046 protects against intestinal inflammation

Por Stančić, Angela, Jandl, Katharina, Hasenöhrl, Carina, Reichmann, Florian, Marsche, Gunther, Schuligoi, Rufina, Heinemann, Akos, Storr, Martin, Schicho, Rudolf
Publicado no Neurogastroenterol Motil (2015)

Eosinophils contribute to intestinal inflammation via chemoattractant receptor-homologous molecule expressed on Th2 cells, CRTH2, in experimental Crohn’s disease

Por Radnai, Balázs, Sturm, Eva M, Stančić, Angela, Jandl, Katharina, Labocha, Sandra, Ferreirós, Nerea, Grill, Magdalena, Hasenoehrl, Carina, Gorkiewicz, Gregor, Marsche, Gunther, Heinemann, Ákos, Högenauer, Christoph, Schicho, Rudolf
Publicado no J Crohns Colitis (2016)

Opposing roles of Prostaglandin D(2) receptors in ulcerative colitis

Por Sturm, Eva M., Radnai, Balazs, Jandl, Katharina, Stančić, Angela, Parzmair, Gerald P., Högenauer, Christoph, Kump, Patrizia, Wenzl, Heimo, Petritsch, Wolfgang, Pieber, Thomas R., Schuligoi, Rufina, Marsche, Gunther, Ferreirós, Nerea, Heinemann, Akos, Schicho, Rudolf
Publicado em 2014